Your browser doesn't support javascript.
loading
Modified influenza M158-66 peptide vaccination induces non-relevant T-cells and may enhance pathology after challenge.
Lanfermeijer, Josien; van de Ven, Koen; van Dijken, Harry; Hendriks, Marion; Talavera Ormeño, Cami M P; de Heij, Femke; Roholl, Paul; Borghans, José A M; van Baarle, Debbie; de Jonge, Jørgen.
Afiliación
  • Lanfermeijer J; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
  • van de Ven K; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • van Dijken H; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
  • Hendriks M; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
  • Talavera Ormeño CMP; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
  • de Heij F; Department of Cell and Chemical Biology, Leiden University Medical Centre, Leiden, The Netherlands.
  • Roholl P; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
  • Borghans JAM; Microscope Consultancy, Weesp, Netherlands.
  • van Baarle D; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • de Jonge J; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
NPJ Vaccines ; 8(1): 116, 2023 Aug 12.
Article en En | MEDLINE | ID: mdl-37573454

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: NPJ Vaccines Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: NPJ Vaccines Año: 2023 Tipo del documento: Article